Plasma Phosphorylated Tau 217 as a Discriminative Biomarker for Cerebral Amyloid Angiopathy
Plasma p-tau 217 may represent a non-invasive biomarker for distinguishing cerebral amyloid angiopathy (CAA) from other conditions, including AD and DPA.
Authors
- Li‐Kai Tsai (ORCID: https://orcid.org/0000-0001-8420-6951)
- Ruoh‐Fang Yen (ORCID: https://orcid.org/0000-0003-1648-6482)
- Hsin-hsi C Tsai (ORCID: https://orcid.org/0000-0002-4721-1468)
- Jiann‐Shing Jeng (ORCID: https://orcid.org/0000-0002-1456-3686)
- Chia‐Ju Liu (ORCID: https://orcid.org/0000-0003-1641-5617)
- Bo‐Ching Lee (ORCID: https://orcid.org/0000-0002-1443-928X)
- Ya‐Chin Tsai
- Pei‐Feng Hsieh
Institutions
- National Taiwan University (TW)
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/ene.70066
- Citations
- 8
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 11.11
Funders
- National Taiwan University Hospital
- National Taiwan University
- National Science and Technology Council